Psoriasis Psoriasis, Phototherapy, Cognitive Behavior Therapy, Disease Severity, Quality of Life, Depression
Conditions
Interventions
Cognitive behavioral therapy is a group activity in which patients receive therapy from a cognitive behavioral therapist once a week for 1 hour and 30 minutes each time for a total of 8 weeks. They ar
feelings of anxiety and sadness.
- Week 3: Relax, feel comfortable, and relax, is to let members learn and practice relaxation skills and share ways to manage stress with each other.
- Week 4: Is thin
Psoriasis patients receiving cognitive behavioral therapy (CBT) in combination with Narrow-band Ultraviolet B Phototherapy (NB-UVB),Psoriasis patients receiving standard Narrow-band Ultraviolet B Phot
Sponsors
Institute of Dermatology
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years and over, both male and female, who have been diagnosed by a doctor with Psoriasis. 2. Have moderate to severe psoriasis (PASI score greater than or equal to 5) 3. Have received narrowband UVB (NB-UVB) radiation 4. Have a tendency to be depressed, with 1 of 2 symptoms, as assessed by the 2-question depression screening form (2Q) 5. Have no problems with hearing, vision, or speech 6. Have full consciousness, can read and write Thai 7. Consent to participate in the study willingly
Exclusion criteria
Exclusion criteria: 1. Patients receiving Biologic drugs 2. Have a history of psychiatric disorders within the past 2 years, such as generalized anxiety disorder, depression, psychosis, schizophrenia, bipolar disorder 3. Are undergoing treatment or receiving antidepressant medication or other psychotropic drugs or receiving other forms of psychotherapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Psoriasis Area and Severity Index Five assessments were performed: before the trial (T0), after the trial (T1), one month after the trial (T2), three months after the trial (T3), and six months after the trial (T4). The PASI score was assessed by a physician | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety and Depression Five assessments were performed: before the trial (T0), after the trial (T1), one month after the trial (T2), three months after the trial (T3), and six months after the trial (T4). questionnaire Thai Hospital Anxiety and Depression Scale (Thai HADS ),Psoriasis Symptom Three assessments were performed: before the trial (T0), after the trial (T1), and six months after the trial (T4). questionnaire PSS,Dermatology Life Quality Index Five assessments were performed: before the trial (T0), after the trial (T1), one month after the trial (T2), three months after the trial (T3), and six months after the trial (T4). questionnaire DLQI,Quality of Life Three assessments were performed: before the trial (T0), after the trial (T1), and six months after the trial (T4). questionnaire EQ-5D-5L | — |
Countries
Thailand
Contacts
Public ContactSirintip Thongkaow
Chulalongkorn University
Outcome results
None listed